Erudio Healtherudio.com
Clinical trial · no report yet · Phase 1/Phase 2
HLD-0915-ONC-101
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- NCT06800313 ↗
- Recruiting
- Janssen Research & Development, LLC
- Focused
We haven't built an HCP commentary report on HLD-0915-ONC-101 (JNJ-101556143 formulation 1, JNJ-101556143 formulation 2 and 1 more in Metastatic Prostate Cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on HLD-0915-ONC-101 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 4 |
The trial
ClinicalTrials.gov- Official title
- Phase 1/2 Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Phase
- Phase 1/Phase 2
- Status
- Recruiting
- Conditions
- Metastatic Prostate Cancer
- Interventions
- JNJ-101556143 Formulation 1; JNJ-101556143 Formulation 2; JNJ-101556143 Formulation 3
- Arms
- JNJ-101556143 Phase 1 Part 1 - Dose Escalation · Experimental
- JNJ-101556143 Phase 1 Part 2 - Formulation Exploration · Experimental
- JNJ-101556143 Phase 2 Part 1 - Dose Optimization · Experimental
- Phase 2 Part 2A - SOAR · Experimental
- Phase 2 Part 2B - HSPC Expansion · Experimental
- Phase 2 Part 2C - HSPC Expansion · Experimental
- Phase 2 Part 2D - HSPC Expansion · Experimental
- Enrollment
- 190 (estimated)
- Primary outcomes
- Frequency of dose-limiting toxicities (DLTs)
- Frequency and severity of AEs and abnormal ECG, laboratory and clinical changes since baseline
- Phase 1 Part 2 (formulation exploration) relative bioavailability
- Sponsor
- Janssen Research & Development, LLC
- Start
- Feb 6, 2025
- Primary completion
- Aug 17, 2028 (estimated)
- Results posted
- No
- Registry record
- NCT06800313 · updated Sep 25, 2026